SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies - Quaterly Results

30 Oct 2021 Evaluate
The turnover soared 62.69% to Rs. 1926.43 millions for the September 2021 quarter as compared to Rs. 1184.08 millions during the corresponding quarter last year.The Net Profit of the company reported a remarkable increase of 229.39% to Rs. 241.28  millions  from Rs. 73.25 millions in previous same quarter.Operating profit surged to 308.97 millions from the corresponding previous quarter of 169.01 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1926.43 1184.08 62.69 3294.91 2981.18 10.52 5146.23 3202.31 60.70
Other Income 29.63 117.39 -74.76 48.81 132.46 -63.15 177.62 35.79 396.28
PBIDT 308.97 169.01 82.81 521.77 392.05 33.09 646.25 466.47 38.54
Interest 0.00 73.33 -100.00 0.00 101.27 -100.00 127.26 130.46 -2.45
PBDT 308.97 171.62 80.03 521.77 275.02 89.72 753.41 247.89 203.93
Depreciation 84.58 83.47 1.33 168.25 166.80 0.87 342.80 310.51 10.40
PBT 224.39 88.15 154.55 353.52 108.22 226.67 410.61 -62.62 -755.72
TAX -16.89 14.90 -213.36 -33.66 14.90 -325.91 -132.12 19.64 -772.71
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 241.28 73.25 229.39 387.18 93.32 314.89 542.73 -82.26 -759.77
Equity 133.67 123.42 8.30 133.67 123.42 8.30 123.42 123.42 0.00
PBIDTM(%) 16.04 14.27 12.37 15.84 13.15 20.42 12.56 14.57 -13.79

Venus Remedies Share Price

1730.00 -5.30 (-0.31%)
08-Jul-2026 11:08 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.35
Dr. Reddys Labs. 1367.85
Cipla 1460.20
Zydus Lifesciences 1170.00
Lupin 2517.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: